Literature DB >> 34313382

New model integrates innate responses, PML-NB formation, epigenetic control and reactivation from latency.

Sandra K Weller1, Neal A Deluca2.   

Abstract

The dynamic nature of interactions between invading viral pathogens and their hosts has fascinated scientists for several decades. The well-known capacity of herpes simplex virus (HSV) to establish life-long infections in humans reflects a dynamic balance between maintaining a latent state in which viral genomes are silenced and re-entry into the lytic phase during reactivation. Silencing of the viral genome has been shown to be a function of innate immune signalling, intrinsic cellular antiviral mechanisms and epigenetic repression. Thus, although many important observations have been made identifying cellular processes that contribute to the repression of the viral genome and latency, the field has lacked an understanding of how these factors work together. In this issue of EMBO Reports, Suzich et al (2021) present convincing evidence that brings together individual observations into a cohesive model that explains many of these outstanding mysteries. Here, we will review the background data that lead to this outstanding piece of work.
© 2021 The Authors.

Entities:  

Mesh:

Year:  2021        PMID: 34313382      PMCID: PMC8419697          DOI: 10.15252/embr.202153496

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   9.071


  11 in total

1.  Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription.

Authors:  S Mittnacht; P Straub; H Kirchner; H Jacobsen
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

2.  PML-NB-dependent type I interferon memory results in a restricted form of HSV latency.

Authors:  Jon B Suzich; Sean R Cuddy; Hiam Baidas; Sara Dochnal; Eugene Ke; Austin R Schinlever; Aleksandra Babnis; Chris Boutell; Anna R Cliffe
Journal:  EMBO Rep       Date:  2021-07-01       Impact factor: 9.071

3.  New model integrates innate responses, PML-NB formation, epigenetic control and reactivation from latency.

Authors:  Sandra K Weller; Neal A Deluca
Journal:  EMBO Rep       Date:  2021-07-27       Impact factor: 9.071

4.  Identification of a novel nuclear domain.

Authors:  C A Ascoli; G G Maul
Journal:  J Cell Biol       Date:  1991-03       Impact factor: 10.539

5.  Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection.

Authors:  Thamir Alandijany; Ashley P E Roberts; Kristen L Conn; Colin Loney; Steven McFarlane; Anne Orr; Chris Boutell
Journal:  PLoS Pathog       Date:  2018-01-08       Impact factor: 6.823

6.  PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX.

Authors:  Erwan Delbarre; Kristina Ivanauskiene; Jane Spirkoski; Akshay Shah; Kristin Vekterud; Jan Øivind Moskaug; Stig Ove Bøe; Lee H Wong; Thomas Küntziger; Philippe Collas
Journal:  Genome Res       Date:  2017-03-24       Impact factor: 9.043

7.  Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.

Authors:  Camille Cohen; Armelle Corpet; Simon Roubille; Mohamed Ali Maroui; Nolwenn Poccardi; Antoine Rousseau; Constance Kleijwegt; Olivier Binda; Pascale Texier; Nancy Sawtell; Marc Labetoulle; Patrick Lomonte
Journal:  PLoS Pathog       Date:  2018-09-20       Impact factor: 6.823

8.  HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.

Authors:  Frédéric Catez; Christel Picard; Kathrin Held; Sylvain Gross; Antoine Rousseau; Diethilde Theil; Nancy Sawtell; Marc Labetoulle; Patrick Lomonte
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

9.  SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes.

Authors:  Delphine Cuchet-Lourenço; Chris Boutell; Vera Lukashchuk; Kyle Grant; Amanda Sykes; Jill Murray; Anne Orr; Roger D Everett
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

Review 10.  Role of polycomb proteins in regulating HSV-1 latency.

Authors:  Zachary Watson; Adit Dhummakupt; Harald Messer; Dane Phelan; David Bloom
Journal:  Viruses       Date:  2013-07-15       Impact factor: 5.048

View more
  1 in total

1.  New model integrates innate responses, PML-NB formation, epigenetic control and reactivation from latency.

Authors:  Sandra K Weller; Neal A Deluca
Journal:  EMBO Rep       Date:  2021-07-27       Impact factor: 9.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.